Bullish
Aktis Oncology Initiates Phase 1b Trial of AKY-2519 in mCRPC
Aktis Oncology has initiated a Phase 1b trial of AKY-2519 for metastatic castration-resistant prostate cancer (mCRPC). This novel radiopharmaceutical ...
AKTS
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (1)
Neutral (0)
Bearish (0)
Latest AKTS News
Bullish
Research AKTS on:
Ad Space